Isabel Lastres‐Becker

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

Isabel Lastres‐Becker, Francisco Molina‐Holgado, J.A. Ramos et al. · Neurobiology of Disease · 2005 · 410 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation

Antonio Cuadrado, Zaira Martín‐Moldes, Jianping Ye et al. · Journal of Biological Chemistry · 2014 · 316 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease

Isabel Lastres‐Becker, Ángel J. García‐Yagüe, Robert H. Scannevin et al. · Antioxidants and Redox Signaling · 2016 · 273 citations · Full text

Medicine, Neuroscience, Pharmacology +17

α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease

Isabel Lastres‐Becker, Ayşe Ulusoy, Nadia G. Innamorato et al. · Human Molecular Genetics · 2012 · 261 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cannabinoid CB₂receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease

Onintza Sagredo, Sara González, Ilia Aroyo et al. · Glia · 2008 · 200 citations

Life Sciences, Neuroscience, Pharmacology +17